patent/EA-200200943-A1

Predicate	Object
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-566 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-566 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04
filingDate	2001-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate	2003-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	EA-200200943-A1
titleOfInvention	HORMONAL THERAPY OF BREAST CANCER
abstract	Exemestane is disclosed for use in the treatment of the first line of metastatic, advanced, hormone-dependent breast cancer, in particular, in postmenopausal women. An international search report was published 2002.07.25.
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MD-24-Z http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MD-23-Z http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MD-35-Z http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MD-36-Z
priorityDate	2000-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554174 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60198

Total number of triples: 23.